Sun Pharma Clarifies Assam Facility News, Links to Q2 Results

Sun Pharmaceutical Industries Ltd has issued a clarification regarding a news report dated October 30, 2026, concerning its Assam facility. The company stated that the reported incident, which involved an order to halt production due to quality lapses, occurred in August 2026 and was assessed at the time. Sun Pharma clarified that this is not a new development and did not warrant disclosure under SEBI Listing Regulations at that point. The company also addressed the share price movement on October 30, 2026, noting that it coincided with the announcement of their financial results for the quarter and half-year ended September 30, 2026. Sun Pharma is unable to attribute the share price movement to any specific factor and confirms no other material undisclosed events.